Home The Word Brain My Amedeo FAQ Privacy About   


C49 + CC Journal Club

For more information, please refer to our special emails from April 13 and May 19.

  Colorectal Neoplasms

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 30 articles:
HTML format



Single Articles


    May 2025
  1. DEANGELO SL, Zhao L, Dziechciarz S, Shin M, et al
    Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer.
    Cancer Res. 2025 May 20. doi: 10.1158/0008-5472.CAN-24-3478.
    PubMed     Abstract available


  2. MATEJCIC M, Teer JK, Hoehn HJ, Diaz DB, et al
    Colorectal Tumors in Diverse Patient Populations Feature a Spectrum of Somatic Mutational Profiles.
    Cancer Res. 2025;85:1928-1944.
    PubMed     Abstract available


  3. BUCKENMEYER MJ, Brooks EA, Taylor MS, Orenuga IK, et al
    A 3D Self-Assembly Platform Integrating Decellularized Matrix Recapitulates In Vivo Tumor Phenotypes and Heterogeneity.
    Cancer Res. 2025;85:1577-1595.
    PubMed     Abstract available


    March 2025
  4. TIKUM AF, Henning NW, Pougoue Ketchemen J, Doroudi A, et al
    An Anti-EGFR Antibody-Drug Radioconjugate Labeled with Actinium-225 Elicits Durable Anti-Tumor Responses in KRAS and BRAF Mutant Colorectal Cancer.
    Cancer Res. 2025 Mar 24. doi: 10.1158/0008-5472.CAN-24-2266.
    PubMed     Abstract available


    February 2025
  5. LIN Y, Zhang Y, Huang T, Chen J, et al
    Arginine Deprivation Induces Quiescence and Confers Vulnerability to Ferroptosis in Colorectal Cancer.
    Cancer Res. 2025 Feb 24. doi: 10.1158/0008-5472.CAN-24-1940.
    PubMed     Abstract available


  6. DENG S, Wang J, Zou F, Cheng D, et al
    Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer.
    Cancer Res. 2025 Feb 24. doi: 10.1158/0008-5472.CAN-24-2892.
    PubMed     Abstract available


  7. XU J, Meng Q, Li X, Yang H, et al
    Correction: Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p.
    Cancer Res. 2025;85:826.
    PubMed    


  8. CASTRO J, Daniels MH, Brennan D, Johnston B, et al
    A Potent, Selective, Small-Molecule Inhibitor of DHX9 Abrogates Proliferation of Microsatellite Instable Cancers with Deficient Mismatch Repair.
    Cancer Res. 2025;85:758-776.
    PubMed     Abstract available


    January 2025
  9. LI D, Liu X, Gao W, Zhao W, et al
    An Immune Subtype Classification System Enables the Development of Strategies to Predict and Enhance Immunotherapy Responses in Colorectal Cancer.
    Cancer Res. 2025 Jan 29. doi: 10.1158/0008-5472.CAN-24-2464.
    PubMed     Abstract available


  10. KALLIO P, Bessone C, Seyednasrollah F, Brodkin J, et al
    A Multipotent PROX1+ Tumor Stem/Progenitor Cell Population Emerges During Intestinal Tumorigenesis and Mediates Radioresistance in Colorectal Cancer.
    Cancer Res. 2025 Jan 22. doi: 10.1158/0008-5472.CAN-23-1851.
    PubMed     Abstract available


    December 2024
  11. JACOB J, Anami Y, High PC, Liang Z, et al
    Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal Cancer.
    Cancer Res. 2024 Dec 18. doi: 10.1158/0008-5472.CAN-24-0798.
    PubMed     Abstract available


  12. CUI L, Liu R, Han S, Zhang C, et al
    Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer.
    Cancer Res. 2024 Dec 9. doi: 10.1158/0008-5472.CAN-24-1611.
    PubMed     Abstract available


  13. GUO X, Luo S, Wang X, Cui Y, et al
    CD24-Targeted NIR-II Fluorescence Imaging Enables Early Detection of Colorectal Neoplasia.
    Cancer Res. 2024;84:4099-4113.
    PubMed     Abstract available


    October 2024
  14. CHUA J, Gregorieff A, Ayyaz A
    Bottom-up or Top-down: Inflammation Reprograms Paneth Cells to Develop Bowel Cancers.
    Cancer Res. 2024;84:3324-3326.
    PubMed     Abstract available


  15. LADAIKA CA, Ghobashi AH, Boulton WC, Miller SA, et al
    LSD1 and CoREST2 Potentiate STAT3 Activity to Promote Enteroendocrine Cell Differentiation in Mucinous Colorectal Cancer.
    Cancer Res. 2024 Oct 4. doi: 10.1158/0008-5472.CAN-24-0788.
    PubMed     Abstract available


  16. ROLFO C, Russo A
    The Next Frontier for Colorectal Cancer Screening: Blood-Based Tests.
    Cancer Res. 2024;84:3128-3129.
    PubMed     Abstract available


    September 2024
  17. WANG H, Chen J, Chen X, Liu Y, et al
    Cancer-Associated Fibroblasts Expressing Sulfatase 1 Facilitate VEGFA-Dependent Microenvironmental Remodeling to Support Colorectal Cancer.
    Cancer Res. 2024 Sep 9. doi: 10.1158/0008-5472.CAN-23-3987.
    PubMed     Abstract available


  18. CHEN D, Ji F, Zhou Q, Cheung H, et al
    RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal Tumorigenesis.
    Cancer Res. 2024;84:2856-2872.
    PubMed     Abstract available


  19. SHU Y, Jin X, Ji M, Zhang Z, et al
    Ku70 Binding to YAP Alters PARP1 Ubiquitination to Regulate Genome Stability and Tumorigenesis.
    Cancer Res. 2024;84:2836-2855.
    PubMed     Abstract available


    August 2024
  20. SAHA S, Ghosh M, Li J, Wen A, et al
    Serine Depletion Promotes Antitumor Immunity by Activating Mitochondrial DNA-Mediated cGAS-STING Signaling.
    Cancer Res. 2024;84:2645-2659.
    PubMed     Abstract available


    July 2024
  21. CAO Y, Wang N, Wu X, Tang W, et al
    Multi-Dimensional Fragmentomics Enables Early and Accurate Detection of Colorectal Cancer.
    Cancer Res. 2024 Jul 29. doi: 10.1158/0008-5472.CAN-23-3486.
    PubMed     Abstract available


  22. LIAO S, Deng J, Deng M, Chen C, et al
    AFDN deficiency promotes liver tropism of metastatic colorectal cancer.
    Cancer Res. 2024 Jul 24. doi: 10.1158/0008-5472.CAN-23-3140.
    PubMed     Abstract available


    June 2024
  23. LI L, Jiang D, Liu H, Guo C, et al
    Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression.
    Cancer Res. 2024 Jun 11. doi: 10.1158/0008-5472.CAN-23-1878.
    PubMed     Abstract available


    May 2024
  24. BAKER AM, Nageswaran G, Nenclares P, Ronel T, et al
    FUME-TCRseq Enables Sensitive and Accurate Sequencing of the T-cell Receptor from Limited Input of Degraded RNA.
    Cancer Res. 2024;84:1560-1569.
    PubMed     Abstract available


  25. BAHRAMBEIGI V, Lee JJ, Branchi V, Rajapakshe KI, et al
    Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-Specific Transcriptome and Molecular Subtype.
    Cancer Res. 2024;84:1719-1732.
    PubMed     Abstract available


    April 2024
  26. YANG S, Zhang D, Sun Q, Nie H, et al
    Single-Cell and Spatial Transcriptome Profiling Identifies the Transcription Factor BHLHE40 as a Driver of EMT in Metastatic Colorectal Cancer.
    Cancer Res. 2024 Apr 24. doi: 10.1158/0008-5472.CAN-23-3264.
    PubMed     Abstract available


  27. ZHAO N, Cao Y, Tao R, Zhu X, et al
    The circMYBL2-encoded p185 protein suppresses colorectal cancer progression by inhibiting serine biosynthesis.
    Cancer Res. 2024 Apr 18. doi: 10.1158/0008-5472.CAN-23-2940.
    PubMed     Abstract available


  28. CHEN Y, Ying Y, Ma W, Ma H, et al
    Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.
    Cancer Res. 2024;84:1237-1251.
    PubMed     Abstract available


    March 2024
  29. MCCOLLUM SE, Shah YM
    Stressing Out Cancer: Chronic Stress Induces Dysbiosis and Enhances Colon Cancer Growth.
    Cancer Res. 2024;84:645-647.
    PubMed     Abstract available


  30. FANG L, Zhang L, Wang M, He Y, et al
    Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial-Mesenchymal Transition.
    Cancer Res. 2024;84:659-674.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.